“The term sheet agreement is to enable Solbio to enter into a definitive agreement to supply 3.5 million doses of the Recombinant Ad5-nCoV vaccine for the prevention of Covid-19. The vaccine is jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnology, Academy of Military Medical Sciences, ” the company said in a filing with Bursa Malaysia.
PETALING JAYA: Technology firm Solution Group Bhd
’s unit Solution Biologics Sdn Bhd (Solbio) said it has signed a term sheet agreement with the Health Ministry to supply Covid-19 vaccines to the government.
“The term sheet agreement is to enable Solbio to enter into a definitive agreement to supply 3.5 million doses of the Recombinant Ad5-nCoV vaccine for the prevention of Covid-19. The vaccine is jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnology, Academy of Military Medical Sciences, ” the company said in a filing with Bursa Malaysia.
Celebrate Merdeka with 50% Off!
T&C applies.
